Position in GNLX
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$3,267
-$2,619 QoQ
Shares Held
1,350
0.0% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2023
11 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in GNLX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026BROWN BROTHERS HARRIMAN & CO holds $9,680,711 across 45 Biotechnology names. GNLX ranks #40 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
5,838 | $2,606,900 | |
| 2 | PCVX |
Vaxcyte, Inc.
|
38,033 | $2,210,097 | |
| 3 | RVMD |
Revolution Medicines, Inc.
|
15,000 | $1,458,750 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,802 | $1,392,297 | |
| 5 | ADMA |
Adma Biologics, Inc.
|
39,973 | $360,156 | |
| 6 | TECH |
BIO-TECHNE Corp
|
6,724 | $351,396 | |
| 7 | MRNA |
Moderna, Inc.
|
6,843 | $347,624 | |
| 8 | INCY |
Incyte Corp
|
1,937 | $182,310 |
All Filings in GNLX
Export CSV
11 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $3,267 | 1,350 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $5,886 | 1,350 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $5,670 | 1,350 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $3,874 | 1,350 | Shares | Sole | 2025-08-11 | |
| 2025-03-31 | $39,012 | 14,449 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $34,099 | 14,449 | Shares | Sole | 2025-02-12 | |
| 2024-09-30 | $49,947 | 21,075 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $23,323 | 11,961 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $76,922 | 11,963 | Shares | Sole | 2024-05-10 | |
| 2023-12-31 | $191,264 | 13,652 | Shares | Sole | 2024-02-12 | |
| 2023-09-30 | $334,410 | 13,655 | Shares | Sole | 2023-11-13 | |
| No filing history on record for this holder in this stock. | ||||||